Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 318

1.

Factors affecting the accuracy of respiratory tracking of the image-guided robotic radiosurgery system.

Inoue M, Okawa K, Taguchi J, Hirota Y, Yanagiya Y, Kikuchi C, Iwabuchi M, Murai T, Iwata H, Shiomi H, Koike I, Tatewaki K, Ohta S.

Jpn J Radiol. 2019 Jul 31. doi: 10.1007/s11604-019-00859-7. [Epub ahead of print]

PMID:
31367890
2.

Prognostic impact of cytogenetic abnormalities in adult patients with Philadelphia chromosome-negative ALL who underwent an allogeneic transplant.

Shimizu H, Doki N, Kanamori H, Sakura T, Mori T, Machida S, Takahashi S, Ohwada C, Fujisawa S, Yano S, Hagihara M, Kanda Y, Onoda M, Gotoh M, Kako S, Taguchi J, Usuki K, Kawai N, Aotsuka N, Okamoto S; Kanto Study Group for Cell Therapy (KSGCT).

Bone Marrow Transplant. 2019 Jun 11. doi: 10.1038/s41409-019-0585-2. [Epub ahead of print]

PMID:
31186516
3.

Successful outcome of second allogeneic bone marrow transplantation for blastic plasmacytoid dendritic cell neoplasm with MYC locus rearrangement.

Kato T, Itonaga H, Taguchi J, Makiyama J, Fujioka M, Taguchi M, Horai M, Sawayama Y, Niino D, Imaizumi Y, Hata T, Yoshida S, Sakamoto K, Takeuchi K, Ohshima K, Miyazaki Y.

Leuk Res Rep. 2019 Apr 22;11:31-33. doi: 10.1016/j.lrr.2019.04.005. eCollection 2019.

4.

Central nervous system post-transplant lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation: The Nagasaki transplant group experience.

Sakamoto H, Itonaga H, Taguchi J, Kato T, Sawayama Y, Hayashi T, Baba S, Moriuchi M, Ohshima K, Yoshida S, Moriuchi Y, Miyazaki Y.

Leuk Res Rep. 2019 Apr 22;11:27-30. doi: 10.1016/j.lrr.2019.04.003. eCollection 2019.

5.

Impact of treatment-related weight changes from diagnosis to hematopoietic stem-cell transplantation on clinical outcome of acute myeloid leukemia.

Ando T, Fujisawa S, Teshigawara H, Ogusa E, Ishii Y, Miyashita K, Motohashi K, Miyazaki T, Tachibana T, Hagihara M, Matsumoto K, Tanaka M, Hashimoto C, Koharazawa H, Fujimaki K, Taguchi J, Fujita H, Kanamori H, Yamazaki E, Nakajima H; Yokohama Cooperative Study Group for Hematology (YACHT).

Int J Hematol. 2019 Jun;109(6):673-683. doi: 10.1007/s12185-019-02647-5. Epub 2019 Apr 8.

PMID:
30963469
6.

Diagnostic Utility of Cytomegalovirus Nucleic Acid Testing during Antigenemia-Guided Cytomegalovirus Monitoring after Hematopoietic Stem Cell Transplantation or Liver Transplantation.

Morinaga Y, Sawayama Y, Hidaka M, Mori S, Taguchi J, Takatsuki M, Eguchi S, Miyazaki Y, Yanagihara K.

Tohoku J Exp Med. 2019 Mar;247(3):179-187. doi: 10.1620/tjem.247.179.

7.

Concise Synthesis of Potassium Acyltrifluoroborates from Aldehydes through Copper(I)-Catalyzed Borylation/Oxidation.

Taguchi J, Takeuchi T, Takahashi R, Masero F, Ito H.

Angew Chem Int Ed Engl. 2019 May 27;58(22):7299-7303. doi: 10.1002/anie.201901748. Epub 2019 Mar 26.

PMID:
30844125
8.

Outcome of patients receiving consolidative autologous peripheral blood stem cell transplantation in the frontline treatment of intravascular large B-cell lymphoma: Adult Lymphoma Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Kato K, Mori T, Kim SW, Sawa M, Sakai T, Hashimoto H, Taguchi J, Oyake T, Kurahashi S, Imada K, Ohno H, Tanaka J, Ichinohe T, Atsuta Y, Suzuki R, Suzumiya J.

Bone Marrow Transplant. 2019 Sep;54(9):1515-1517. doi: 10.1038/s41409-019-0491-7. Epub 2019 Feb 26. No abstract available.

PMID:
30809035
9.

[Gingival squamous cell carcinoma diagnosed on the occasion of osteonecrosis of the jaw in a patient with chronic GVHD].

Tsukada S, Itonaga H, Taguchi J, Miyoshi T, Hayashida S, Sato S, Ando K, Sawayama Y, Imaizumi Y, Hata T, Umeda M, Niino D, Miyazaki Y.

Rinsho Ketsueki. 2019;60(1):22-27. doi: 10.11406/rinketsu.60.22. Japanese.

PMID:
30726819
10.

Phase Ib/II single-arm trial evaluating the combination of everolimus, lapatinib and capecitabine for the treatment of HER2-positive breast cancer with brain metastases (TRIO-US B-09).

Hurvitz S, Singh R, Adams B, Taguchi JA, Chan D, Dichmann RA, Castrellon A, Hu E, Berkowitz J, Mani A, DiCarlo B, Callahan R, Smalberg I, Wang X, Meglar I, Martinez D, Hobbs E, Slamon DJ.

Ther Adv Med Oncol. 2018 Nov 9;10:1758835918807339. doi: 10.1177/1758835918807339. eCollection 2018.

11.

Complete remission of pure white cell aplasia associated with thymoma after thymectomy and cyclosporine administration.

Kobayashi Y, Ando K, Hata T, Imaizumi Y, Nagai K, Kamijyo R, Katoh T, Taguchi J, Itonaga H, Sato S, Sawayama Y, Miyazaki Y.

Int J Hematol. 2019 Mar;109(3):346-350. doi: 10.1007/s12185-018-02573-y. Epub 2018 Dec 9.

PMID:
30535832
12.

Primary Oral Mucormycosis Due to Rhizopus microsporus after Allogeneic Stem Cell Transplantation.

Sakamoto H, Itonaga H, Sawayama Y, Taguchi J, Saijo T, Kuwatsuka S, Hashisako M, Kinoshita N, Oishi M, Doi H, Kosai K, Nishimoto K, Tanaka K, Yanagihara K, Mukae H, Izumikawa K, Miyazaki Y.

Intern Med. 2018;57(17):2567-2571. doi: 10.2169/internalmedicine.0474-17. Epub 2018 Sep 1.

13.

The outcome and characteristics of patients with relapsed adult T cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation.

Kato K, Uike N, Wake A, Yoshimitsu M, Tobai T, Sawayama Y, Takatsuka Y, Fukuda T, Uchida N, Eto T, Nakashima Y, Kondo T, Taguchi J, Miyamoto T, Nakamae H, Ichinohe T, Kato K, Suzuki R, Utsunomiya A; ATL Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Hematol Oncol. 2019 Feb;37(1):54-61. doi: 10.1002/hon.2558. Epub 2018 Sep 28.

PMID:
30171618
14.

Early prediction of lenvatinib treatment efficacy by using 18F-FDG PET/CT in patients with unresectable or advanced thyroid carcinoma that is refractory to radioiodine treatment: a protocol for a non-randomized single-arm multicenter observational study.

Takeuchi S, Shiga T, Hirata K, Taguchi J, Magota K, Ariga S, Gouda T, Ohhara Y, Homma R, Shimizu Y, Kinoshita I, Tsuji Y, Homma A, Iijima H, Tamaki N, Dosaka-Akita H.

BMJ Open. 2018 Aug 30;8(8):e021001. doi: 10.1136/bmjopen-2017-021001.

15.

Primary uterine lymphoma: The Yokohama Cooperative Study Group for Hematology (YACHT) study.

Ishii Y, Fujisawa S, Ando T, Suzuki T, Ishiyama Y, Kishimoto K, Hattori Y, Nakajima Y, Miyazaki T, Takasaki H, Matsumoto K, Koharazawa H, Taguchi J, Fujimaki K, Sakai R, Nakajima H.

Asia Pac J Clin Oncol. 2018 Oct;14(5):e455-e459. doi: 10.1111/ajco.13049. Epub 2018 Jul 8.

PMID:
29984481
16.

Pilot study of WT1 peptide-pulsed dendritic cell vaccination with docetaxel in esophageal cancer.

Matsuda T, Takeuchi H, Sakurai T, Mayanagi S, Booka E, Fujita T, Higuchi H, Taguchi J, Hamamoto Y, Takaishi H, Kawakubo H, Okamoto M, Sunamura M, Kawakami Y, Kitagawa Y.

Oncol Lett. 2018 Jul;16(1):1348-1356. doi: 10.3892/ol.2018.8734. Epub 2018 May 17.

17.

[Durable remission attained with plasmapheresis and intravenous immunoglobulin therapy in a patient with acute exacerbation of GVHD-related myasthenia gravis].

Nakashima J, Itonaga H, Fujioka M, Chiwata M, Sawayama Y, Yoshimura S, Iwanaga H, Taguchi J, Yoshida S, Miyazaki Y.

Rinsho Ketsueki. 2018;59(5):480-484. doi: 10.11406/rinketsu.59.480. Japanese.

PMID:
29877233
18.

TAS-114, a First-in-Class Dual dUTPase/DPD Inhibitor, Demonstrates Potential to Improve Therapeutic Efficacy of Fluoropyrimidine-Based Chemotherapy.

Yano W, Yokogawa T, Wakasa T, Yamamura K, Fujioka A, Yoshisue K, Matsushima E, Miyahara S, Miyakoshi H, Taguchi J, Chong KT, Takao Y, Fukuoka M, Matsuo K.

Mol Cancer Ther. 2018 Aug;17(8):1683-1693. doi: 10.1158/1535-7163.MCT-17-0911. Epub 2018 May 10.

19.

Clinical Significance of Serum Ferritin at Diagnosis in Patients With Acute Myeloid Leukemia: A YACHT Multicenter Retrospective Study.

Tachibana T, Andou T, Tanaka M, Ito S, Miyazaki T, Ishii Y, Ogusa E, Koharazawa H, Takahashi H, Motohashi K, Aoki J, Nakajima Y, Matsumoto K, Hagihara M, Hashimoto C, Taguchi J, Fujimaki K, Fujita H, Fujisawa S, Kanamori H, Nakajima H; Yokohama Cooperative Study Group for Hematology (YACHT).

Clin Lymphoma Myeloma Leuk. 2018 Jun;18(6):415-421. doi: 10.1016/j.clml.2018.03.009. Epub 2018 Mar 31.

PMID:
29673622
20.

EPOCH regimen as salvage therapy for adult T-cell leukemia-lymphoma.

Toriyama E, Imaizumi Y, Taniguchi H, Taguchi J, Nakashima J, Itonaga H, Sato S, Ando K, Sawayama Y, Hata T, Fukushima T, Miyazaki Y.

Int J Hematol. 2018 Aug;108(2):167-175. doi: 10.1007/s12185-018-2455-x. Epub 2018 Apr 12.

PMID:
29651666
21.

Detection rates and sites of unruptured intracranial aneurysms according to sex and age: an analysis of MR angiography-based brain examinations of 4070 healthy Japanese adults.

Imaizumi Y, Mizutani T, Shimizu K, Sato Y, Taguchi J.

J Neurosurg. 2018 Apr 6;130(2):573-578. doi: 10.3171/2017.9.JNS171191.

PMID:
29624149
22.

Late Onset of Non-islet Cell Tumor Hypoglycemia Managed via Multidisciplinary Treatment in a Patient with a Solitary Fibrous Tumor.

Takeuchi S, Goda T, Taguchi J, Douhata Y, Honma R, Ariga S, Ohhara Y, Shimizu Y, Kinoshita I, Fukuda I, Nagashima Y, Akita H.

Intern Med. 2018 Aug 15;57(16):2431-2436. doi: 10.2169/internalmedicine.0231-17. Epub 2018 Mar 9.

23.

Long-lasting memory of cellular immunity in a chronic myeloid leukemia patient maintains molecular response 5 after cessation of dasatinib.

Jo T, Noguchi K, Hayashi S, Irie S, Hayase R, Shioya H, Kaneko Y, Horio K, Taguchi J.

Oncol Lett. 2018 Mar;15(3):2935-2938. doi: 10.3892/ol.2017.7720. Epub 2017 Dec 29.

24.

Efficacy and Long-Term Outcomes of Autologous Stem Cell Transplantation in POEMS Syndrome: A Nationwide Survey in Japan.

Kawajiri-Manako C, Sakaida E, Ohwada C, Miyamoto T, Azuma T, Taguchi J, Mori T, Hasegawa Y, Kondo T, Yujiri T, Yoshimitsu M, Imada K, Kurahashi S, Kahata K, Ichinohe T, Hirokawa M, Atsuta Y, Nakaseko C.

Biol Blood Marrow Transplant. 2018 Jun;24(6):1180-1186. doi: 10.1016/j.bbmt.2018.01.026. Epub 2018 Feb 1.

25.

Phase II trial of combination treatment with paclitaxel, carboplatin and cetuximab (PCE) as first-line treatment in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CSPOR-HN02).

Tahara M, Kiyota N, Yokota T, Hasegawa Y, Muro K, Takahashi S, Onoe T, Homma A, Taguchi J, Suzuki M, Minato K, Yane K, Ueda S, Hara H, Saijo K, Yamanaka T.

Ann Oncol. 2018 Apr 1;29(4):1004-1009. doi: 10.1093/annonc/mdy040.

PMID:
29408977
26.

Regulatory T cell inhibition by dasatinib is associated with natural killer cell differentiation and a favorable molecular response-The final results of the D-first study.

Najima Y, Yoshida C, Iriyama N, Fujisawa S, Wakita H, Chiba S, Okamoto S, Kawakami K, Takezako N, Kumagai T, Ohyashiki K, Taguchi J, Yano S, Igarashi T, Kouzai Y, Morita S, Sakamoto J, Sakamaki H, Inokuchi K.

Leuk Res. 2018 Mar;66:66-72. doi: 10.1016/j.leukres.2018.01.010. Epub 2018 Feb 3.

PMID:
29407585
27.

Chromosomal analysis of myelodysplastic syndromes among atomic bomb survivors in Nagasaki.

Horai M, Satoh S, Matsuo M, Iwanaga M, Horio K, Jo T, Takasaki Y, Kawaguchi Y, Tsushima H, Yoshida S, Taguchi M, Itonaga H, Sawayama Y, Taguchi J, Imaizumi Y, Hata T, Moriuchi Y, Haase D, Yoshiura KI, Miyazaki Y.

Br J Haematol. 2018 Feb;180(3):381-390. doi: 10.1111/bjh.15050. Epub 2017 Dec 19.

PMID:
29265181
28.

Synthesis of Acylborons by Ozonolysis of Alkenylboronates: Preparation of an Enantioenriched Amino Acid Acylboronate.

Taguchi J, Ikeda T, Takahashi R, Sasaki I, Ogasawara Y, Dairi T, Kato N, Yamamoto Y, Bode JW, Ito H.

Angew Chem Int Ed Engl. 2017 Oct 23;56(44):13847-13851. doi: 10.1002/anie.201707933. Epub 2017 Sep 29.

PMID:
28905460
29.

In vivo reprogramming for tissue regeneration and organismal rejuvenation.

Taguchi J, Yamada Y.

Curr Opin Genet Dev. 2017 Oct;46:132-140. doi: 10.1016/j.gde.2017.07.008. Epub 2017 Aug 2. Review.

PMID:
28779646
30.

Development of a modified prognostic index for patients with aggressive adult T-cell leukemia-lymphoma aged 70 years or younger: possible risk-adapted management strategies including allogeneic transplantation.

Fuji S, Yamaguchi T, Inoue Y, Utsunomiya A, Moriuchi Y, Uchimaru K, Owatari S, Miyagi T, Taguchi J, Choi I, Otsuka E, Nakachi S, Yamamoto H, Kurosawa S, Tobinai K, Fukuda T.

Haematologica. 2017 Jul;102(7):1258-1265. doi: 10.3324/haematol.2017.164996. Epub 2017 Mar 24.

31.

Peptide-pulsed dendritic cell vaccine in combination with carboplatin and paclitaxel chemotherapy for stage IV melanoma.

Fukuda K, Funakoshi T, Sakurai T, Nakamura Y, Mori M, Tanese K, Tanikawa A, Taguchi J, Fujita T, Okamoto M, Amagai M, Kawakami Y.

Melanoma Res. 2017 Aug;27(4):326-334. doi: 10.1097/CMR.0000000000000342.

PMID:
28263240
32.

Unveiling the Role of Senescence-Induced Cellular Plasticity.

Taguchi J, Yamada Y.

Cell Stem Cell. 2017 Mar 2;20(3):293-294. doi: 10.1016/j.stem.2017.02.001.

33.

"Everyone Deserves to be Remembered Like This": Videotaped Autobiography and End-of-Life Discussions Among Those With Serious or Terminal Illness.

Kogan AC, Kobashigawa W, Taguchi J, Carter K.

J Pain Symptom Manage. 2017 Jul;54(1):e1-e3. doi: 10.1016/j.jpainsymman.2017.02.001. Epub 2017 Feb 21. No abstract available.

34.

Body mass index is a prognostic factor in adult patients with acute myeloid leukemia.

Ando T, Yamazaki E, Ogusa E, Ishii Y, Yamamoto W, Motohashi K, Tachibana T, Hagihara M, Matsumoto K, Tanaka M, Hashimoto C, Koharazawa H, Fujimaki K, Taguchi J, Fujita H, Kanamori H, Fujisawa S, Nakajima H; Yokohama Cooperative Study Group for Hematology (YACHT).

Int J Hematol. 2017 May;105(5):623-630. doi: 10.1007/s12185-017-2183-7. Epub 2017 Jan 21.

PMID:
28110409
35.

Dismal outcome of allogeneic hematopoietic stem cell transplantation for relapsed adult T-cell leukemia/lymphoma, a Japanese nation-wide study.

Fujiwara H, Fuji S, Wake A, Kato K, Takatsuka Y, Fukuda T, Taguchi J, Uchida N, Miyamoto T, Hidaka M, Miyazaki Y, Tomoyose T, Onizuka M, Takanashi M, Ichinohe T, Atsuta Y, Utsunomiya A; ATL Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Bone Marrow Transplant. 2017 Mar;52(3):484-488. doi: 10.1038/bmt.2016.313. Epub 2017 Jan 9. No abstract available.

PMID:
28067877
36.

Thymoma-associated multi-organ autoimmunity: two cases and a review of the literature.

Shiba K, Fujita Y, Miyazawa H, Muramatsu K, Watanabe M, Nishimura M, Shinkuma S, Nomura T, Nishie W, Taguchi J, Kinoshita I, Shimizu H.

J Eur Acad Dermatol Venereol. 2017 Jul;31(7):e324-e326. doi: 10.1111/jdv.14108. Epub 2017 Jan 23. Review. No abstract available.

PMID:
28052464
37.

Dynamic profile analysis to characterize dynamics-driven allosteric sites in enzymes.

Taguchi J, Kitao A.

Biophys Physicobiol. 2016 Jul 14;13:117-126. eCollection 2016.

38.

Clinical features and prognosis of patients with myelodysplastic syndromes who were exposed to atomic bomb radiation in Nagasaki.

Matsuo M, Iwanaga M, Kondo H, Soda M, Jo T, Horio K, Takasaki Y, Kawaguchi Y, Tsushima H, Imaizumi Y, Imanishi D, Taguchi J, Sawayama Y, Hata T, Miyazaki Y.

Cancer Sci. 2016 Oct;107(10):1484-1491. doi: 10.1111/cas.13025. Epub 2016 Sep 2.

39.

Association of pleural effusion with an early molecular response in patients with newly diagnosed chronic-phase chronic myeloid leukemia receiving dasatinib: Results of a D-First study.

Hagihara M, Iriyama N, Yoshida C, Wakita H, Chiba S, Okamoto S, Kawakami K, Takezako N, Kumagai T, Inokuchi K, Ohyashiki K, Taguchi J, Yano S, Igarashi T, Kouzai Y, Morita S, Sakamoto J, Sakamaki H.

Oncol Rep. 2016 Nov;36(5):2976-2982. doi: 10.3892/or.2016.5110. Epub 2016 Sep 20.

PMID:
27665844
40.

Outcome and prognostic factors among patients who underwent a second transplantation for disease relapse post the first allogeneic cell transplantation.

Tachibana T, Matsumoto K, Tanaka M, Hagihara M, Motohashi K, Yamamoto W, Ogusa E, Koyama S, Numata A, Tomita N, Taguchi J, Fujisawa S, Kanamori H, Nakajima H.

Leuk Lymphoma. 2017 Jun;58(6):1403-1411. doi: 10.1080/10428194.2016.1243678. Epub 2016 Oct 14.

PMID:
27739916
41.

[Diagnostic Utilities of an Automated and Standardized DNA Quantification during Cytomegalovirus Monitoring].

Mori S, Morinaga Y, Nishimura F, Murata M, Umihata S, Sasaki D, Kaku N, Kosai K, Uno N, Taguchi J, Hasegawa H, Miyazaki Y, Yanagihara K.

Rinsho Byori. 2016 Aug;64(8):881-886. Japanese.

PMID:
30609324
42.

The SIL index is a simple and objective prognostic indicator in diffuse large B-cell lymphoma.

Tomita N, Suzuki T, Miyashita K, Yamamoto W, Motohashi K, Tachibana T, Takasaki H, Kawasaki R, Hagihara M, Hashimoto C, Takemura S, Koharazawa H, Yamazaki E, Taguchi J, Fujimaki K, Fujita H, Sakai R, Fujisawa S, Motomura S, Kawamoto K, Sone H, Takizawa J.

Leuk Lymphoma. 2016 Dec;57(12):2763-2770. Epub 2016 Jun 20.

PMID:
27320054
43.

Hyper-recovery of platelets after induction therapy is a predictor of relapse-free survival in acute myeloid leukemia.

Yamazaki E, Kanamori H, Itabashi M, Ogusa E, Numata A, Yamamoto W, Ito S, Tachibana T, Hagihara M, Matsumoto K, Koharazawa H, Taguchi J, Tomita N, Fujimaki K, Fujita H, Fujisawa S, Ogawa K, Ishigatsubo Y.

Leuk Lymphoma. 2017 Jan;58(1):104-109. Epub 2016 Jun 7.

PMID:
27267543
44.

Acute megakaryoblastic leukemia, unlike acute erythroid leukemia, predicts an unfavorable outcome after allogeneic HSCT.

Ishiyama K, Yamaguchi T, Eto T, Ohashi K, Uchida N, Kanamori H, Fukuda T, Miyamura K, Inoue Y, Taguchi J, Mori T, Iwato K, Morishima Y, Nagamura-Inoue T, Atsuta Y, Sakamaki H, Takami A.

Leuk Res. 2016 Aug;47:47-53. doi: 10.1016/j.leukres.2016.04.017. Epub 2016 May 12.

PMID:
27244257
45.

Adult T-cell leukemia/lymphoma in donor cells responding to second allogeneic hematopoietic stem cell transplantation using unrelated cord blood: the Nagasaki Transplant Group experience.

Itonaga H, Taguchi J, Taguchi M, Taniguchi H, Sato S, Sawayama Y, Imaizumi Y, Yoshida S, Hata T, Moriuchi Y, Miyazaki Y.

Leuk Lymphoma. 2016 Dec;57(12):2946-2948. Epub 2016 May 23. No abstract available.

PMID:
27210445
46.

[Evaluation of the Effect of Adiabatic Pulse and B1 Shim to the Radio Frequency Homogeneity in Chemical Shift Imaging].

Kikuchi C, Inoue M, Okawa K, Taguchi J, Hirota Y, Yanagiya Y.

Nihon Hoshasen Gijutsu Gakkai Zasshi. 2016 Apr;72(4):326-33. doi: 10.6009/jjrt.2016_JSRT_72.4.326. Japanese.

47.

Daily Repetitive Transcranial Magnetic Stimulation for Poststroke Upper Limb Paresis in the Subacute Period.

Hosomi K, Morris S, Sakamoto T, Taguchi J, Maruo T, Kageyama Y, Kinoshita Y, Goto Y, Shimokawa T, Koyama T, Saitoh Y.

J Stroke Cerebrovasc Dis. 2016 Jul;25(7):1655-1664. doi: 10.1016/j.jstrokecerebrovasdis.2016.02.024. Epub 2016 Apr 7.

48.

Lenalidomide in relapsed adult T-cell leukaemia-lymphoma or peripheral T-cell lymphoma (ATLL-001): a phase 1, multicentre, dose-escalation study.

Ogura M, Imaizumi Y, Uike N, Asou N, Utsunomiya A, Uchida T, Aoki T, Tsukasaki K, Taguchi J, Choi I, Maruyama D, Nosaka K, Chen N, Midorikawa S, Ohtsu T, Tobinai K.

Lancet Haematol. 2016 Mar;3(3):e107-18. doi: 10.1016/S2352-3026(15)00284-7. Epub 2016 Feb 12.

PMID:
26947199
49.

Iridium(I)-catalyzed C-H Borylation of α,β-Unsaturated Esters with Bis(pinacolato)diboron.

Sasaki I, Taguchi J, Doi H, Ito H, Ishiyama T.

Chem Asian J. 2016 May 6;11(9):1400-5. doi: 10.1002/asia.201600078. Epub 2016 Apr 5.

50.

Supplemental Content

Loading ...
Support Center